Pharmaceutical Companies Face Difficulties Navigating Evolving Biologic Transport Regulations

Share Article

IQPC’s 8th Transportation & Transfer of Biologics and Biological Agents Summit addresses the security, quality & compliance of biologic operations.

News Image
The number one violation we see is with training, or the lack thereof.

Pharma IQ, a division of IQPC, announces the 8th Transportation & Transfer of Biologics and Biological Agents Summit, being held April 30 to May 2, 2012 in San Francisco, CA. The summit will address trends and concerns within the field, including quality assurance, logistics, regulation, tracing and distribution.

Sixty percent of revenue growth for pharmaceutical companies moving forward is projected to come from biologics. The distribution and transfer of biologics is becoming more complex as companies become more global. Markets are becoming more international and more organizations are looking to utilize CMOs and CROs in other countries as well as distribute to a broader region.

As regulation evolves with the expansion, many companies have difficulties navigating complex regulations for transporting biologic material. As noted by Jack Whitley, Transportation Specialist at the US Department of Transportation, in a recent interview, “The number one violation we see is with training, or the lack thereof. A good training program will provide a safe and sturdy foundation for all involved.” To learn more about best practices for compliance with 49 CFR Hazardous Materials Regulations, read the interview in its entirety here: [http://www.transportbiologics.com/redForms.aspx?id=685650&sform_id=719006

A host of expert speakers from organizations including Johnson & Johnson, Chartis, Biogen Idec, the FAA and more offer insights and best practice strategies on the following points:

  •     Understanding both international and domestic regulation
  •     Investigating biohazardous considerations and biosafety
  •     Processes and techniques for the transportation of biologics
  •     Improving the quality of shipments
  •     Developing best practices in regards to shipment and warehouse security

Understanding all the potential pitfalls and how to avoid delays For more information on the 8th Transportation & Transfer of Biologics and Biological Agents Summit please visit http://www.transportbiologics.com or contact Robert Littlefield, Program Director at Robert.Littlefield(at)iqpc(dot)com.

About IQPC:
IQPC (http://www.iqpc.com) provides business executives with tailored practical conferences, large-scale events, topical seminars and in-house training programs. Producing over 1,500 events annually around the world, IQPC continues to grow and has offices in cities across six continents including: Berlin, Dubai, London, New York, Sao Paulo, Singapore, Sydney, and Toronto.

Contact:
IQPC
Taryn Soltysiak
T: +1 212-885-2695
F: +1 888-231-7864
http://www.iqpc.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Taryn Soltysiak
IQPC
212 885 2679
Email >

Rob Littlefield
IQPC
212 885 2797
Email >